Synergy Asset Management’s Evogene EVGN Stock Holding History

Synergy Asset Management’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20	Closed	-$61	–	301
2024 Q4	$61	Buy	+20	New	+$39	﹤0.01%	851

Other funds holding EVGN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Synergy Asset Management's EVGN Position: Q1 2025 in Review

Synergy Asset Management sold out of Evogene (EVGN) in Q1 2025, closing a stake of 20 shares — an estimated $61 sold.

Synergy Asset Management first reported a position in EVGN in Q4 2024 and held it in 1 quarter. The position peaked at $61 in Q4 2024. 16 funds tracked by Wall St. Rank hold EVGN as of Q1 2025.

Synergy Asset Management reported no remaining Evogene position as of Q1 2025 after selling out during the quarter.
Synergy Asset Management sold 20 Evogene shares in Q1 2025, an estimated $61.
Synergy Asset Management first reported a position in Evogene in Q4 2024 and held it in 1 quarter.
Synergy Asset Management's Evogene position peaked at $61 in Q4 2024.
16 funds tracked by Wall St. Rank held Evogene as of Q1 2025.

Based on Synergy Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.